| Metric | This Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥121.0B | ¥93.5B | +29.4% |
| Operating Income / Operating Profit | ¥1.9B | ¥0.7B | +153.4% |
| Profit Before Tax | ¥0.9B | ¥0.6B | +46.8% |
| Net Income / Net Profit | ¥0.7B | ¥0.3B | +97.1% |
| ROE | 0.2% | 0.1% | - |
For Q1 of the fiscal year ending March 2026, Revenue was ¥121.0B (¥93.5B in the prior-year period, +¥27.5B +29.4%), Operating Income was ¥1.9B (¥0.7B, +¥1.2B +153.4%), Ordinary Income was ¥0.0B (decrease of ¥0.5B from ¥0.5B in the prior year), and Net Income was ¥0.7B (¥0.3B, +¥0.4B +97.1%). Revenue maintained high growth, and gross margin improved substantially to 53.9% (48.6% prior year, +5.3pt), driving a doubling of Operating Income. However, finance costs expanded to ¥1.3B (¥0.6B prior year), absorbing roughly 70% of Operating Income and limiting Profit Before Tax to ¥0.9B (¥0.6B prior year, +48%). Operating margin was 1.5% (0.8% prior year, +0.7pt), remaining positive, but Interest Coverage (EBIT ¥1.9B / finance costs ¥1.3B) is about 1.5x, indicating that interest burden continues to pressure profitability. Progress against the full-year plan (Revenue ¥540.1B, Operating Income ¥43.1B, Net Income ¥34.6B) stands at 22.4% for Revenue, 4.3% for Operating Income, and 2.0% for Net Income, signaling slow profit ramp-up and a strong assumption of second-half weighting.
[Revenue] Revenue expanded robustly to ¥121.0B (YoY +29.4%). As a single-segment company (AaaS Business), detailed segmental disclosure is not provided, but Gross Profit was ¥65.3B (gross margin 53.9%, improvement of +5.3pt from 48.6% prior year), indicating significant profitability improvement likely attributable to improved customer mix and product-mix optimization. Accounts receivable were ¥128.5B (¥106.0B at prior fiscal year-end, +¥22.5B), and contract assets were ¥45.7B (¥47.7B at prior fiscal year-end, -¥2.0B), so receivables accumulation and elongation of collection terms alongside revenue growth are putting pressure on working capital. Contract liabilities were ¥5.3B (¥5.2B at prior fiscal year-end), remaining flat with limited buildup of deferred revenue. R&D expense was ¥16.9B (13.9% of Revenue), reflecting continued active investment to strengthen future competitiveness.
[Profitability] Against Gross Profit of ¥65.3B, Selling & Marketing expenses were ¥40.6B (33.6% of Revenue), R&D ¥16.9B (13.9%), and G&A ¥7.0B (5.8%), for total operating expenses of ¥64.5B. Total SG&A is high at 53.3% of Revenue, and while Operating Income of ¥1.9B (Operating margin 1.5%) is positive, economies of scale have not fully materialized. Selling expenses rose from ¥28.6B to ¥40.6B (+42%), outpacing Revenue growth, with upfront customer acquisition costs delaying improvement in operating leverage. Financial income was ¥0.3B against finance costs of ¥1.3B, for net finance costs of -¥1.0B, and Other income ¥1.1B vs Other expenses ¥0.1B for net other income +¥1.0B. Non-operating items broadly offset, yielding Profit Before Tax of ¥0.9B (¥0.6B prior year, +48%). The increase in finance costs is due to higher borrowings (short-term borrowings ¥46.4B, ¥37.9B at prior fiscal year-end, +¥8.5B; long-term borrowings ¥63.8B, ¥57.5B at prior fiscal year-end, +¥6.3B) and rising interest rates; annualized finance cost relative to interest-bearing debt of ¥110.2B is approximately 4.6%. After corporate tax expense of ¥0.2B (effective tax rate 24.2%), Net Income was ¥0.7B (Net margin 0.6%, an improvement of +0.2pt from 0.4% prior year). In conclusion, while revenue and profit increased alongside improved gross margin, upfront selling expenses and interest burdens have slowed improvement in operating and net margins, making full-scale monetization largely dependent on the second half of the fiscal year.
[Profitability] Operating margin 1.5% (0.8% prior year, +0.7pt) and Net margin 0.6% (0.4% prior year, +0.2pt) remain positive but at low levels. EBITDA is approximately ¥13.3B (EBIT ¥1.9B + depreciation & amortization ¥11.5B), giving an EBITDA margin around 11.0%, indicating double-digit cash-based earning power excluding non-cash amortization. ROE is 0.2% (Net Income ¥0.7B / Equity ¥377.1B), extremely low and showing mid-course for capital efficiency improvement. The Sales-to-Operating-Income ratio indicates insufficient operating leverage, primarily due to high Selling expense at 33.6% of Revenue. Gross margin of 53.9% is a significant improvement from 48.6%, confirming progress in product competitiveness and cost control.
[Cash Quality] Operating Cash Flow (OCF) was -¥13.8B, far below Net Income of ¥0.7B, with OCF/Net Income at -20x, highlighting weak cash conversion. OCF/EBITDA is -1.04x, so cash generation is negative even on an EBITDA basis. Working capital deterioration (accounts receivable increase -¥20.8B, accounts payable decrease -¥3.4B) is the main driver, with credit extension and longer billing/collection cycles tied to revenue growth pressuring working capital.
[Investment Efficiency] Capital expenditure was ¥0.1B, small in scale, but intangible asset acquisitions were ¥15.2B (from investing CF breakdown), showing active in-house development investment. Including R&D of ¥16.9B (13.9% of Revenue), a growth-investment posture is maintained. Total asset turnover is 0.20x (Revenue ¥121.0B / average total assets ¥609.0B), low and indicating substantial room to improve asset efficiency.
[Financial Health] Equity Ratio is 61.5% (61.4% at prior fiscal year-end), high and solid. Interest-bearing debt totaled ¥110.2B (short-term borrowings ¥46.4B, long-term borrowings ¥63.8B) while cash & cash equivalents were ¥118.9B, maintaining net cash of approximately +¥8.7B. Current ratio is 2.26x (current assets ¥366.1B / current liabilities ¥161.9B), and Debt/Equity is 29.2%, reflecting conservative liquidity and leverage metrics. Interest Coverage is about 1.5x (EBIT ¥1.9B / finance costs ¥1.3B), indicating limited tolerance for interest burden; buffer against interest rate rises or higher borrowings is small. Goodwill and intangible assets of ¥214.9B represent 35% of total assets, so ongoing monitoring for impairment risk remains important.
Operating Cash Flow was -¥13.8B (worsened by ¥2.2B from -¥11.6B prior year), significantly below Net Income of ¥0.7B, indicating continued weak cash generation. From subtotal -¥13.7B (before working capital changes), increases in trade receivables -¥20.8B, contract assets +¥2.7B, and decreases in accounts payable -¥3.4B led to working capital congestion causing roughly -¥21.5B of cash outflow. The increase in receivables is linked to revenue growth; however, while Revenue grew +29.4%, receivables increased +21.2%, suggesting elongation of collection periods. Interest received ¥0.7B, interest paid -¥0.4B, and corporate taxes paid -¥0.4B left core operating cash generation negative. Investing CF was +¥4.4B (net inflow), driven by term deposit maturities of ¥24.9B exceeding intangible asset acquisitions -¥15.2B and subsidiary acquisitions -¥5.3B; on a substantive basis, investments in PP&E and intangibles were -¥15.3B, reflecting active investment. Free Cash Flow (FCF) was -¥9.4B (Operating CF -¥13.8B + Investing CF +¥4.4B), so funding for growth investments and dividends is being sourced from Financing CF. Financing CF was +¥10.5B, consisting of net increases in short-term borrowings +¥8.5B and net increases in long-term borrowings +¥6.2B, funding dividend payments -¥2.3B and lease repayments -¥1.9B. Cash & cash equivalents rose from ¥117.3B at the beginning of the period to ¥118.9B at period-end, an increase of +¥1.6B, aided by foreign exchange translation effects of +¥0.6B. Working capital deterioration due to revenue growth is a structural issue; strengthening collections and shortening billing cycles are urgent management priorities.
Non-operating results are dominated by finance costs of -¥1.3B, which absorb about 70% of Operating Income ¥1.9B; hence the quality of Profit Before Tax is heavily dependent on interest burden. Financial income ¥0.3B (interest & dividends received) is small at 0.2% of Revenue and provides limited recurring contribution. Net other income of +¥1.0B (Other income ¥1.1B, Other expenses ¥0.1B) is 0.8% of Revenue and small in scale, indicating low non-recurring nature of non-operating income. Non-operating items are largely explained by interest results, with no obvious one-off special items. Accrual ratio is 2.4% (e.g., increase in receivables / Net Income ¥0.7B), a reasonable level, but because Operating CF is negative, cash quality of earnings is weak. Corporate tax of ¥0.2B on Profit Before Tax ¥0.9B yields an effective tax rate of 24.2%, standard with no abnormal discrepancy. The gap between Ordinary Income and Net Income is explained by heavy finance costs, with no impact from extraordinary gains/losses. Overall, dependence on non-operating income is low and earnings composition is healthy, but weak cash conversion reduces earnings quality.
The full-year plan targets Revenue ¥540.1B (year-on-year change not disclosed; annualized from Q1 implies a high-growth assumption), Operating Income ¥43.1B (YoY +44.9%), and Net Income ¥34.6B (YoY +35.4%). Q1 progress vs. full-year plan is Revenue 22.4% (121.0/540.1), Operating Income 4.3% (1.9/43.1), and Net Income 2.0% (0.7/34.6), below a standard quarterly run-rate of 25%, with particularly slow profit ramp-up. Full-year EPS is forecast at ¥33.95, and Dividend forecast is ¥0, signaling a priority on reinvesting internally for growth. As of Q1, there are no revisions to earnings or dividend forecasts, and management judges full-year targets achievable. The lag in progress is attributed to upfront Selling & Marketing and R&D investment and working capital deterioration causing temporary margin contraction, with the assumption that operating leverage will improve in the second half as economies of scale emerge. To achieve the full-year targets, increasing EBITDA margin through Q2 onwards, improving selling-cost efficiency, normalizing working capital, and containing interest burden are essential. While the progress shortfall may be within an expected second-half weighting of the budget, monitoring Q2 onward performance is critical to assess full-year probability.
Dividend payments in the period were ¥2.3B (¥2.0B prior year, +15%), while the full-year dividend forecast is ¥0. For Q1 alone, the payout ratio is temporarily high (dividends ¥2.3B / Net Income ¥0.7B implying payout ratio ≈330%), but this reflects the timing of the previous fiscal year-end dividend payment; the full-year policy is no dividend. No share buybacks were executed (¥0.0B). Total return ratio is driven solely by dividends, indicating a clear priority on growth investment over shareholder distributions. With cash at ¥118.9B and FCF at -¥9.4B, continued dividend payments would rely on financing CF such as borrowings. Sustainability of the payout policy depends on OCF turning positive and profit growth; prioritizing internal retention for intangible asset acquisitions and R&D to enhance corporate value is considered appropriate for the near term.
Working Capital Deterioration Risk: Accounts receivable are ¥128.5B (¥106.0B at prior fiscal year-end, +21.2%) and, while increasing at a lower rate than Revenue growth (+29.4%), have risen materially in absolute terms and are elongating receivable days, pressuring working capital. With Operating CF at -¥13.8B, persistent negative OCF and delayed corrective measures on credit management and collection terms may escalate liquidity risk and borrowing dependence. Combined with contract assets of ¥45.7B, total sales-related receivables are ¥174.2B, representing 28% of total assets, necessitating close monitoring of collection risk.
Rising Interest Burden Risk: Interest-bearing debt of ¥110.2B with finance costs of ¥1.3B implies an annualized rate of about 4.6%, and Interest Coverage (EBIT/finance costs) is about 1.5x, indicating low resilience to interest burden. If interest rates rise at rollover of short-term borrowings of ¥46.4B, the majority of Operating Income could be absorbed, squeezing Profit Before Tax. Finance costs of ¥1.3B versus Operating Income ¥1.9B consume about 70%, making the company highly vulnerable to changes in interest rates or further increases in borrowings.
Intangible Asset Impairment Risk: Goodwill and intangible assets of ¥214.9B represent 35% of total assets, reflecting accumulated M&A and in-house development capitalizations. If future cash flow projections fall short of expectations, impairment losses could be recorded, eroding equity. There are no clear impairment indicators as of Q1, but given the low Operating margin of 1.5%, divergence from expected returns could increase impairment testing sensitivity.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 1.5% | 6.2% (4.2%–17.2%) | -4.7pt |
| Net Margin | 0.6% | 2.8% (0.6%–11.9%) | -2.2pt |
Both Operating and Net margins are below industry medians, placing the company in the lower tier for profitability. Upfront selling expenses and interest burden are the main causes, and realization of economies of scale is a key challenge.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 29.4% | 20.9% (12.5%–25.8%) | +8.4pt |
Revenue growth exceeds the industry median, positioning the company in the upper tier for growth. Top-line expansion suggests competitive advantage, but the pace of monetization remains an issue.
※ Source: Company compilation
If strong Revenue growth of +29.4% and a simultaneous gross margin improvement of +5.3pt continue, operating leverage should emerge and Operating margin should increase. Achieving full-year guidance (Operating margin 8.0%, ¥43.1B / ¥540.1B) requires significant second-half improvement, but maintaining Q1 gross margin levels and improving selling-cost efficiency would increase achievability. An EBITDA margin of 11% indicates cash-based earning power and suggests that, excluding amortization burden, a double-digit margin foundation exists.
Operating Cash Flow of -¥13.8B and weak cash conversion is the primary focus. Structural issues from elongating receivable days and working capital congestion mean that progress in collections and shortening billing cycles are critical KPIs. Without improvement in OCF/EBITDA from -1.04x, rising borrowing dependence and higher interest costs may offset gains from margin improvement. Whether OCF turns positive and FCF becomes positive within the fiscal year will be the litmus test for sustainable growth.
Interest Coverage of about 1.5x and heavy interest burden present a bottleneck for a borrowing-dependent growth model. Although the company maintains net cash (cash ¥118.9B vs interest-bearing debt ¥110.2B), negative Operating CF means liquidity depends on external funding. Changes in interest rate environment or deterioration of borrowing terms could rapidly reduce profitability. Reducing borrowings or expanding EBITDA to lower interest burden ratio is essential to improve financial stability.
This report is an AI-generated financial analysis document created by analyzing XBRL earnings disclosure data. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by our firm from publicly disclosed financial statements. Investment decisions should be made at your own responsibility; please consult a professional advisor as necessary.